Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Torasemide significantly reduces thiazide-induced potassium and magnesium loss despite supra-additive natriuresis

    Resistance to high-dose loop diuretics can be overcome either by co-administration with thiazides or by treatment with medium-dose loop diuretics combined with thiazides. Combination therapy has been proven to...

    H. Knauf, E. Mutschler, H. Velazquez in European Journal of Clinical Pharmacology (2009)

  2. No Access

    Article

    The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects

    Thiazide diuretics are known to induce a transient fall of the glomerular filtration rate (GFR), which, in turn, reduces tubular Na+ load. This tubuloglomerular feedback (TGF) curtails the natriuretic effect of t...

    H. Knauf, M. A. Bailey, G. Hasenfuss in European Journal of Clinical Pharmacology (2006)

  3. No Access

    Chapter

    Therapie der essenziellen Hypertonie

    Es ist unstrittig, dass lebensstiländernde Maßnahmen den erhöhten Blutdruck erheblich senken und vor allen Dingen in ihrer Komplexität unter Verwendung verschiedener Strategien den Effekt einer medikamentösen ...

    I.-W. Franz, F. Keller, J. Rosenthal, H. Knauf, E. Mutschler in Arterielle Hypertonie (2004)

  4. No Access

    Chapter

    Thiazide Diuretics

    Thiazide diuretics have been in existence for more than 3 decades. They are benzothiadiazines or analogs and derivatives of the carbonic anhydrase–inhibiting sulfonamides. Their synthesis was spawned by a sear...

    H. Velázquez, H. Knauf, E. Mutscler in Diuretics (1995)

  5. No Access

    Chapter

    Potassium-Retaining Diuretics: Triamterene

    Triamterene belongs to the class of cyclic amidine diuretics along with amiloride. The core structure of triamterene (Fig. 3) is a pteridine ring which is substituted in the 2, 4, and 7 positions by amino grou...

    T. Netzer, F. Ullrich, H. Knauf, E. Mutschler in Diuretics (1995)

  6. No Access

    Article

    The saluretic effect of the thiazide diuretic bemetizide in relation to the glomerular filtration rate

    The effect of the thiazide diuretic, bemetizide, on the excretion of Na+, K+, Cl, Ca2+, and Mg2+ in relation to the glomerular filtration rate (GFR) was studied in 17 subjects whose creatinine clearances ranged ...

    H. Knauf, W. Cawello, G. Schmidt, E. Mutschler in European Journal of Clinical Pharmacology (1994)

  7. No Access

    Article

    Pharmacodynamic and kinetic considerations on diuretics as a basis for differential therapy

    Diuretics are classified according to their site of action in the nephron: loop diuretics, thiazides, and antikaliuretics. During peak diuresis the pattern of electrolyte excretion is constant and characterist...

    H. Knauf, E. Mutschler in Klinische Wochenschrift (1991)

  8. No Access

    Chapter

    Effects of Piretanide on Sodium and Potassium Excretion and on Renal Hemodynamics

    The efficacy of 6mg piretanide given orally on Na and K+ excretion as well as on renal hemodynamics was studied in 14 patients, with a GFR (Inulin-Clearance) ranging from 140 to 2 ml/min. Piretanide induced a nat...

    H. Knauf, E. Mutschler, R. Pooth, G. Thum in New Therapeutic Strategies in Nephrology (1991)

  9. No Access

    Article

    Comparative enantioselective pharmacokinetic studies of celiprolol in healthy volunteers and patients with impaired renal function

    The pharmacokinetics of the ß1-selective adrenergic antagonist (R,S)-celiprolol has been studied after oral administration of 200 mg celiprolol-HCl to 8 healthy volunteers and 8 patients with various degrees of i...

    C. Hartmann, M. Frölich, D. Krauß in European Journal of Clinical Pharmacology (1990)

  10. No Access

    Article

    Saluretic effect of the loop diuretic torasemide in chronic renal failure

    The effects of torasemide have been studied in 7 healthy controls and 9 patients with stable chronic renal failure of various degrees.

    H. Knauf, E. Mutschler in European Journal of Clinical Pharmacology (1990)

  11. No Access

    Article

    Pharmacokinetics of torasemide and its metabolites in healthy controls and in chronic renal failure

    The pharmacokinetics of 20 mg torasemide i.v. has been studied in 7 healthy controls and 9 patients with varying degrees of renal impairment.

    H. Spahn, H. Knauf, E. Mutschler in European Journal of Clinical Pharmacology (1990)

  12. No Access

    Article

    Gemfibrozil absorption and elimination in kidney and liver disease

    The disposition of the lipid-lowering drug gemfibrozil was studied in patients with either renal (n= 8) or hepatic disease (n= 8) and compared to those of healthy volunteers (n= 6). Gemfibrozil was determined in ...

    H. Knauf, E. U. Kölle, E. Mutschler in Klinische Wochenschrift (1990)

  13. No Access

    Article

    Prediction of diuretic mobilization of cirrhotic ascites by pretreatment fractional sodium excretion

    In a randomized prospective study the efficacy and side effects of xipamide versus the combination spironolactone/furosemide in the treatment of cirrhotic ascites were studied. Out of 27 patients four responde...

    H. Knauf, E. Wenk, J. Schölmerich, K. J. Goerg, W. Gerok in Klinische Wochenschrift (1990)

  14. No Access

    Article

    Single- and multiple-dose pharmacokinetics of R-(−)- and S-(+)-prenylamine in man

    The pharmacokinetics of S-(+)- and R-(−)-prenylamine was studied in eight healthy volunteers given single and repeated oral doses of the racemic drug.

    Y. Gietl, H. Spahn, H. Knauf, E. Mutschler in European Journal of Clinical Pharmacology (1990)

  15. No Access

    Chapter and Conference Paper

    Diuretikatherapie im Alter

    Diuretika gehören nicht nur zu den für die Behandlung von Herz-Kreislauf-Erkrankungen bedeutsamen Arzneistoffgruppen, sondern auch zu den am häufigsten bei alten Menschen eingesetzten Medikamenten. Etwa 50–60%...

    E. Mutschler, H. Knauf, W. Möhrke in Verhandlungen der Deutschen Gesellschaft f… (1990)

  16. No Access

    Chapter and Conference Paper

    Diuretika und Vasodilatantien bei Herzinsuffizienz

    Die zunächst nützlichen Mechanismen zur Kompensation einer Herzinsuffizienz können derartig gesteigert sein, daß sie ihrerseits zum wesentlichen Faktor für die Manifestation der Herzinsuffizienz werden. Diese ...

    H. Knauf in Arteriosklerose (1989)

  17. No Access

    Article

    Pharmacokinetics of amiloride in renal and hepatic disease

    The pharmacokinetics of the antikaliuretic amiloride has been studied in healthy controls and in patients with chronic renal failure or hepatitis. It was 40% bound to protein.

    H. Spahn, K. Reuter, E. Mutschler, W. Gerok in European Journal of Clinical Pharmacology (1987)

  18. No Access

    Chapter

    Pharmacodynamics and kinetics of torasemide and its metabolites in chronic renal failure after i.v. administration of 20 mg torasemide

    Torasemide is a new loop diuretic with a similar pharmacodynamic action as furosemide. In contrast to furosemide, which is predominantly excreted unchanged, torasemide undergoes extensive oxidative biotransfor...

    H. Spahn, H. Knauf, E. Mutschler in Diuretics: Basic, Pharmacological, and Clinical Aspects (1987)

  19. No Access

    Article

    Modelling of colonic Cl and K+ transport under resting and secreting conditions

    Transport of electrolytes, particularly of Cl and K+, by the rat proximal colon was studied in vivo under conditions of high and low K+ diet and in the presence of transport inhibitors and secretagogues. The ele...

    H. Knauf, K. Haag in Pflügers Archiv (1986)

  20. No Access

    Chapter and Conference Paper

    Neuere Aspekte der Pharmakokinetik von Diuretika

    Seit vor weniger als 30 Jahren das erste oral wirksame Diuretikum in die Therapie eingeführt worden ist, hat die Wirkstoffgruppe der Diuretika immer mehr an Bedeutung gewonnen. Zahlreiche Substanzen mit unters...

    E. Mutschler, H. Spahn, H. Knauf in Diuretika III (1986)

previous disabled Page of 3